Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Reduction of filaritic lymphoedema and elephantiasis by 5,6 benzo-a-pyrone (coumarin), and the effects of diethylcarbamazine (DEC)

Identifieur interne : 000D75 ( PascalFrancis/Curation ); précédent : 000D74; suivant : 000D76

Reduction of filaritic lymphoedema and elephantiasis by 5,6 benzo-a-pyrone (coumarin), and the effects of diethylcarbamazine (DEC)

Auteurs : J. R. Casley-Smith [Australie] ; S. Jamal ; J. R. Casley-Smith

Source :

RBID : Pascal:93-0640187

Descripteurs français

English descriptors

Abstract

Chronic filaritic lymphoedema and elephantiasis, in India, were treated orally with 5,6 benzo-a-pyrone (56 BaP; 1,2 benzo-a-pyrone; coumarin) in a double-blind, randomized, matched-group trial. Each group finally contained 40-55 patients. Patients were observed for about 2 years (ranging from 6 to 45 months, with 75% completing the 2 years). The 56 BaP slowly, but very significantly (P < 0.0001), reduced all grades of lymphoedema and elephantiasis. Two thirds of the oedema was lost by grade 2 over 2 years. Grades 3 to 5 were reduced by a fifth over that time. The greater the initial oedema, the greater was its rate of resolution
pA  
A01 01  1    @0 0003-4983
A02 01      @0 ATMPA2
A03   1    @0 Ann. trop. med. parasitol.
A05       @2 87
A06       @2 3
A08 01  1  ENG  @1 Reduction of filaritic lymphoedema and elephantiasis by 5,6 benzo-a-pyrone (coumarin), and the effects of diethylcarbamazine (DEC)
A11 01  1    @1 CASLEY-SMITH (J. R.)
A11 02  1    @1 JAMAL (S.)
A11 03  1    @1 CASLEY-SMITH (J. R.)
A14 01      @1 Univ. Adelaide, Henry Thomas lab. @2 Adelaide SA 5001 @3 AUS @Z 1 aut.
A20       @1 247-258
A21       @1 1993
A23 01      @0 ENG
A43 01      @1 INIST @2 2075 @5 354000035427770040
A44       @0 0000
A45       @0 26 ref.
A47 01  1    @0 93-0640187
A60       @1 P
A61       @0 A
A64   1    @0 Annals of tropical medicine and parasitology
A66 01      @0 GBR
C01 01    ENG  @0 Chronic filaritic lymphoedema and elephantiasis, in India, were treated orally with 5,6 benzo-a-pyrone (56 BaP; 1,2 benzo-a-pyrone; coumarin) in a double-blind, randomized, matched-group trial. Each group finally contained 40-55 patients. Patients were observed for about 2 years (ranging from 6 to 45 months, with 75% completing the 2 years). The 56 BaP slowly, but very significantly (P < 0.0001), reduced all grades of lymphoedema and elephantiasis. Two thirds of the oedema was lost by grade 2 over 2 years. Grades 3 to 5 were reduced by a fifth over that time. The greater the initial oedema, the greater was its rate of resolution
C02 01  X    @0 002B02S06
C02 02  X    @0 235
C03 01  X  FRE  @0 Lymphoedème @5 01
C03 01  X  ENG  @0 Lymphedema @5 01
C03 01  X  SPA  @0 Linfedema @5 01
C03 02  X  FRE  @0 Eléphantiasis @5 02
C03 02  X  ENG  @0 Elephantiasis @5 02
C03 02  X  SPA  @0 Elefantiasis @5 02
C03 03  X  FRE  @0 Diéthylcarbamazine @2 NK @2 FR @5 03
C03 04  X  FRE  @0 Filariose @2 NM @2 L1 @5 06
C03 04  X  ENG  @0 Filariosis @2 NM @2 L1 @5 06
C03 04  X  SPA  @0 Filariosis @2 NM @2 L1 @5 06
C03 05  X  FRE  @0 Système lymphatique @2 L1 @5 07
C03 05  X  ENG  @0 Lymphatic system @2 L1 @5 07
C03 05  X  SPA  @0 Sistema linfático @2 L1 @5 07
C03 06  X  FRE  @0 Antiparasitaire @5 18
C03 06  X  ENG  @0 Parasiticid @5 18
C03 06  X  SPA  @0 Antiparasitario @5 18
C03 07  X  FRE  @0 Anthelminthique @5 19
C03 07  X  ENG  @0 Anthelmintic @5 19
C03 07  X  SPA  @0 Antihelmíntico @5 19
C03 08  X  FRE  @0 Inde @2 NG @5 44
C03 08  X  ENG  @0 India @2 NG @5 44
C03 08  X  GER  @0 Indien @2 NG @5 44
C03 08  X  SPA  @0 India @2 NG @5 44
C03 09  X  FRE  @0 Coumarine dérivé @2 NK @2 FR @5 94
C03 09  X  ENG  @0 Coumarine derivatives @2 NK @2 FR @5 94
C03 10  X  FRE  @0 Homme @5 95
C03 10  X  ENG  @0 Human @5 95
C03 10  X  SPA  @0 Hombre @5 95
C07 01  X  FRE  @0 Nématodose
C07 01  X  ENG  @0 Nematod disease
C07 01  X  SPA  @0 Nematodosis
C07 02  X  FRE  @0 Helminthiase
C07 02  X  ENG  @0 Helminthiasis
C07 02  X  SPA  @0 Helmintiasis
C07 03  X  FRE  @0 Infection
C07 03  X  ENG  @0 Infection
C07 03  X  SPA  @0 Infección
C07 04  X  FRE  @0 Asie @2 NG
C07 04  X  ENG  @0 Asia @2 NG
C07 04  X  GER  @0 Asien @2 NG
C07 04  X  SPA  @0 Asia @2 NG
N21       @1 328

Links toward previous steps (curation, corpus...)


Links to Exploration step

Pascal:93-0640187

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Reduction of filaritic lymphoedema and elephantiasis by 5,6 benzo-a-pyrone (coumarin), and the effects of diethylcarbamazine (DEC)</title>
<author>
<name sortKey="Casley Smith, J R" sort="Casley Smith, J R" uniqKey="Casley Smith J" first="J. R." last="Casley-Smith">J. R. Casley-Smith</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Univ. Adelaide, Henry Thomas lab.</s1>
<s2>Adelaide SA 5001</s2>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>Australie</country>
</affiliation>
</author>
<author>
<name sortKey="Jamal, S" sort="Jamal, S" uniqKey="Jamal S" first="S." last="Jamal">S. Jamal</name>
</author>
<author>
<name sortKey="Casley Smith, J R" sort="Casley Smith, J R" uniqKey="Casley Smith J" first="J. R." last="Casley-Smith">J. R. Casley-Smith</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">93-0640187</idno>
<date when="1993">1993</date>
<idno type="stanalyst">PASCAL 93-0640187 INIST</idno>
<idno type="RBID">Pascal:93-0640187</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000D33</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000D75</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Reduction of filaritic lymphoedema and elephantiasis by 5,6 benzo-a-pyrone (coumarin), and the effects of diethylcarbamazine (DEC)</title>
<author>
<name sortKey="Casley Smith, J R" sort="Casley Smith, J R" uniqKey="Casley Smith J" first="J. R." last="Casley-Smith">J. R. Casley-Smith</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Univ. Adelaide, Henry Thomas lab.</s1>
<s2>Adelaide SA 5001</s2>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>Australie</country>
</affiliation>
</author>
<author>
<name sortKey="Jamal, S" sort="Jamal, S" uniqKey="Jamal S" first="S." last="Jamal">S. Jamal</name>
</author>
<author>
<name sortKey="Casley Smith, J R" sort="Casley Smith, J R" uniqKey="Casley Smith J" first="J. R." last="Casley-Smith">J. R. Casley-Smith</name>
</author>
</analytic>
<series>
<title level="j" type="main">Annals of tropical medicine and parasitology</title>
<title level="j" type="abbreviated">Ann. trop. med. parasitol.</title>
<idno type="ISSN">0003-4983</idno>
<imprint>
<date when="1993">1993</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Annals of tropical medicine and parasitology</title>
<title level="j" type="abbreviated">Ann. trop. med. parasitol.</title>
<idno type="ISSN">0003-4983</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Anthelmintic</term>
<term>Coumarine derivatives</term>
<term>Elephantiasis</term>
<term>Filariosis</term>
<term>Human</term>
<term>India</term>
<term>Lymphatic system</term>
<term>Lymphedema</term>
<term>Parasiticid</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Lymphoedème</term>
<term>Eléphantiasis</term>
<term>Diéthylcarbamazine</term>
<term>Filariose</term>
<term>Système lymphatique</term>
<term>Antiparasitaire</term>
<term>Anthelminthique</term>
<term>Inde</term>
<term>Coumarine dérivé</term>
<term>Homme</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr">
<term>Inde</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr">
<term>Homme</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Chronic filaritic lymphoedema and elephantiasis, in India, were treated orally with 5,6 benzo-a-pyrone (56 BaP; 1,2 benzo-a-pyrone; coumarin) in a double-blind, randomized, matched-group trial. Each group finally contained 40-55 patients. Patients were observed for about 2 years (ranging from 6 to 45 months, with 75% completing the 2 years). The 56 BaP slowly, but very significantly (P < 0.0001), reduced all grades of lymphoedema and elephantiasis. Two thirds of the oedema was lost by grade 2 over 2 years. Grades 3 to 5 were reduced by a fifth over that time. The greater the initial oedema, the greater was its rate of resolution</div>
</front>
</TEI>
<inist>
<standard h6="B">
<pA>
<fA01 i1="01" i2="1">
<s0>0003-4983</s0>
</fA01>
<fA02 i1="01">
<s0>ATMPA2</s0>
</fA02>
<fA03 i2="1">
<s0>Ann. trop. med. parasitol.</s0>
</fA03>
<fA05>
<s2>87</s2>
</fA05>
<fA06>
<s2>3</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG">
<s1>Reduction of filaritic lymphoedema and elephantiasis by 5,6 benzo-a-pyrone (coumarin), and the effects of diethylcarbamazine (DEC)</s1>
</fA08>
<fA11 i1="01" i2="1">
<s1>CASLEY-SMITH (J. R.)</s1>
</fA11>
<fA11 i1="02" i2="1">
<s1>JAMAL (S.)</s1>
</fA11>
<fA11 i1="03" i2="1">
<s1>CASLEY-SMITH (J. R.)</s1>
</fA11>
<fA14 i1="01">
<s1>Univ. Adelaide, Henry Thomas lab.</s1>
<s2>Adelaide SA 5001</s2>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
</fA14>
<fA20>
<s1>247-258</s1>
</fA20>
<fA21>
<s1>1993</s1>
</fA21>
<fA23 i1="01">
<s0>ENG</s0>
</fA23>
<fA43 i1="01">
<s1>INIST</s1>
<s2>2075</s2>
<s5>354000035427770040</s5>
</fA43>
<fA44>
<s0>0000</s0>
</fA44>
<fA45>
<s0>26 ref.</s0>
</fA45>
<fA47 i1="01" i2="1">
<s0>93-0640187</s0>
</fA47>
<fA60>
<s1>P</s1>
</fA60>
<fA61>
<s0>A</s0>
</fA61>
<fA64 i2="1">
<s0>Annals of tropical medicine and parasitology</s0>
</fA64>
<fA66 i1="01">
<s0>GBR</s0>
</fA66>
<fC01 i1="01" l="ENG">
<s0>Chronic filaritic lymphoedema and elephantiasis, in India, were treated orally with 5,6 benzo-a-pyrone (56 BaP; 1,2 benzo-a-pyrone; coumarin) in a double-blind, randomized, matched-group trial. Each group finally contained 40-55 patients. Patients were observed for about 2 years (ranging from 6 to 45 months, with 75% completing the 2 years). The 56 BaP slowly, but very significantly (P < 0.0001), reduced all grades of lymphoedema and elephantiasis. Two thirds of the oedema was lost by grade 2 over 2 years. Grades 3 to 5 were reduced by a fifth over that time. The greater the initial oedema, the greater was its rate of resolution</s0>
</fC01>
<fC02 i1="01" i2="X">
<s0>002B02S06</s0>
</fC02>
<fC02 i1="02" i2="X">
<s0>235</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE">
<s0>Lymphoedème</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG">
<s0>Lymphedema</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA">
<s0>Linfedema</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE">
<s0>Eléphantiasis</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG">
<s0>Elephantiasis</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA">
<s0>Elefantiasis</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE">
<s0>Diéthylcarbamazine</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>03</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE">
<s0>Filariose</s0>
<s2>NM</s2>
<s2>L1</s2>
<s5>06</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG">
<s0>Filariosis</s0>
<s2>NM</s2>
<s2>L1</s2>
<s5>06</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA">
<s0>Filariosis</s0>
<s2>NM</s2>
<s2>L1</s2>
<s5>06</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE">
<s0>Système lymphatique</s0>
<s2>L1</s2>
<s5>07</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG">
<s0>Lymphatic system</s0>
<s2>L1</s2>
<s5>07</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA">
<s0>Sistema linfático</s0>
<s2>L1</s2>
<s5>07</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE">
<s0>Antiparasitaire</s0>
<s5>18</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG">
<s0>Parasiticid</s0>
<s5>18</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA">
<s0>Antiparasitario</s0>
<s5>18</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE">
<s0>Anthelminthique</s0>
<s5>19</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG">
<s0>Anthelmintic</s0>
<s5>19</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA">
<s0>Antihelmíntico</s0>
<s5>19</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE">
<s0>Inde</s0>
<s2>NG</s2>
<s5>44</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG">
<s0>India</s0>
<s2>NG</s2>
<s5>44</s5>
</fC03>
<fC03 i1="08" i2="X" l="GER">
<s0>Indien</s0>
<s2>NG</s2>
<s5>44</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA">
<s0>India</s0>
<s2>NG</s2>
<s5>44</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE">
<s0>Coumarine dérivé</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>94</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG">
<s0>Coumarine derivatives</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>94</s5>
</fC03>
<fC03 i1="10" i2="X" l="FRE">
<s0>Homme</s0>
<s5>95</s5>
</fC03>
<fC03 i1="10" i2="X" l="ENG">
<s0>Human</s0>
<s5>95</s5>
</fC03>
<fC03 i1="10" i2="X" l="SPA">
<s0>Hombre</s0>
<s5>95</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE">
<s0>Nématodose</s0>
</fC07>
<fC07 i1="01" i2="X" l="ENG">
<s0>Nematod disease</s0>
</fC07>
<fC07 i1="01" i2="X" l="SPA">
<s0>Nematodosis</s0>
</fC07>
<fC07 i1="02" i2="X" l="FRE">
<s0>Helminthiase</s0>
</fC07>
<fC07 i1="02" i2="X" l="ENG">
<s0>Helminthiasis</s0>
</fC07>
<fC07 i1="02" i2="X" l="SPA">
<s0>Helmintiasis</s0>
</fC07>
<fC07 i1="03" i2="X" l="FRE">
<s0>Infection</s0>
</fC07>
<fC07 i1="03" i2="X" l="ENG">
<s0>Infection</s0>
</fC07>
<fC07 i1="03" i2="X" l="SPA">
<s0>Infección</s0>
</fC07>
<fC07 i1="04" i2="X" l="FRE">
<s0>Asie</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="04" i2="X" l="ENG">
<s0>Asia</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="04" i2="X" l="GER">
<s0>Asien</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="04" i2="X" l="SPA">
<s0>Asia</s0>
<s2>NG</s2>
</fC07>
<fN21>
<s1>328</s1>
</fN21>
</pA>
</standard>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PascalFrancis/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000D75 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/biblio.hfd -nk 000D75 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    PascalFrancis
   |étape=   Curation
   |type=    RBID
   |clé=     Pascal:93-0640187
   |texte=   Reduction of filaritic lymphoedema and elephantiasis by 5,6 benzo-a-pyrone (coumarin), and the effects of diethylcarbamazine (DEC)
}}

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024